<DOC>
	<DOCNO>NCT00141271</DOCNO>
	<brief_summary>This 6-week trial evaluate efficacy safety Geodon ( ziprasidone ) outpatient subject age 18 old Bipolar Disorder type I , depress . Subjects require undergo washout period least 7 day prior med .</brief_summary>
	<brief_title>A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>Subjects must primary diagnosis Bipolar I Disorder , recent episode depress , without rapid cycling , without psychotic feature , define Diagnostic Statistical Manual ( Mental Disorders ) Fourth Edition Text Revision ( DSMIVTR ) ( 296.5X ) confirm structured Mini International Neuropsychiatric Interview ( MINI ) Subjects DSMIV TR diagnosis schizophrenia ( 295.XX ) , schizoaffective disorder ( 295.70 ) , schizophreniform disorder ( 295.40 ) , delusional disorder ( 297.1 ) , psychotic disorder otherwise specify ( 298.9 ) . Subjects DSMIV TR Axis I Axis II disorder ( addition Bipolar I disorder ) ineligible comorbid condition clinically unstable , require treatment , primary focus treatment within 6 month period prior screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Bipolar I Disorder</keyword>
</DOC>